10-K
XBRL
FORM 10-K
- Company
- Lexaria Bioscience Corp.
- Filed
- October 15, 2020
- Period of Report
- August 31, 2020
- Accession Number
- 0001640334-20-002561
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →